BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19119125)

  • 1. Angiokeratoma induced by injection of etanercept for psoriasis.
    Bathelier E; Gunera-Saad N; Bérard F; Nicolas JF
    J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S124-5. PubMed ID: 19119125
    [No Abstract]   [Full Text] [Related]  

  • 2. Subgroup analyses of etanercept in pediatric patients with psoriasis.
    Paller AS; Eichenfield LF; Langley RG; Leonardi CL; Siegfried EC; Creamer K; Kricorian G
    J Am Acad Dermatol; 2010 Aug; 63(2):e38-41. PubMed ID: 20633781
    [No Abstract]   [Full Text] [Related]  

  • 3. Etanercept in a 7-year-old boy with severe and recalcitrant psoriasis.
    Safa G; Loppin M; Bousser AM; Barbarot S
    J Am Acad Dermatol; 2007 Feb; 56(2 Suppl):S19-20. PubMed ID: 17097376
    [No Abstract]   [Full Text] [Related]  

  • 4. Lichen planopilaris noted during etanercept therapy in a child with severe psoriasis.
    Abbasi NR; Orlow SJ
    Pediatr Dermatol; 2009; 26(1):118. PubMed ID: 19250435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple lentigines arising in resolving psoriatic plaques after treatment with etanercept.
    Costa LA; Belinchón I; Betlloch I; Pérez-Crespo M; Mataix J
    Dermatol Online J; 2008 Jan; 14(1):11. PubMed ID: 18319028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent varicella in an adult psoriasis patient treated with etanercept.
    Becart S; Segaert S
    Dermatology; 2008; 217(3):260-1. PubMed ID: 18667825
    [No Abstract]   [Full Text] [Related]  

  • 7. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
    Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etanercept treatment in a hemodialysis patient with severe cyclosporine-resistant psoriasis and hepatitis C virus infection.
    Cassano N; Vena GA
    Int J Dermatol; 2008 Sep; 47(9):980-1. PubMed ID: 18937672
    [No Abstract]   [Full Text] [Related]  

  • 9. Recall injection-site reactions to etanercept in a patient with psoriasis.
    Papadavid E; Makris M; Dalamaga M; Kalogeromitros D; Stavrianeas N
    Clin Exp Dermatol; 2009 Apr; 34(3):414-5. PubMed ID: 19120391
    [No Abstract]   [Full Text] [Related]  

  • 10. Facial granulomatous nodules during etanercept treatment for psoriasis.
    Samimi M; Lorette G; Machet L; de Muret A; Watier H; Maruani A
    Int J Dermatol; 2009 Sep; 48(9):1025-7. PubMed ID: 19703000
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of Crohn disease in a patient on etanercept for psoriasis.
    Ahmad K; Rogers S
    Br J Dermatol; 2007 Aug; 157(2):396. PubMed ID: 17573878
    [No Abstract]   [Full Text] [Related]  

  • 12. Etanercept and recalcitrant acrodermatitis continua of Hallopeau.
    Nikkels AF; Piérard GE
    J Drugs Dermatol; 2006 Sep; 5(8):705-6. PubMed ID: 16991229
    [No Abstract]   [Full Text] [Related]  

  • 13. Palmoplantar pustulosis with arthro-osteitis: successful treatment with etanercept and acitretin.
    Antoniou C; Nicolaidou E; Moustou AE; Stratigos A; Katsambas A
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):854-5. PubMed ID: 19646137
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neutropenia and thrombocytopenia in a patient presenting psoriasis treated with etanercept].
    Lahbabi I; Adamski H; Le Jean S; Cannieux V; Polard E; Chevrant-Breton J
    Ann Dermatol Venereol; 2008 May; 135(5):409-10. PubMed ID: 18457732
    [No Abstract]   [Full Text] [Related]  

  • 15. Suspected rapid-onset neutropenia following etanercept use: disproved following rechallenge and lessons to be learned.
    Sachdev A; Shwayder T
    Int J Dermatol; 2013 Oct; 52(10):1287-8. PubMed ID: 22417135
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-induced bullous pemphigoid: cases triggered by intravenous iodine and etanercept.
    Kluk J; Goulding JM; Bhat J; Finch TM
    Clin Exp Dermatol; 2011 Dec; 36(8):871-3. PubMed ID: 21623885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe hypoglycemia after initiation of anti-tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2 diabetes mellitus.
    Wambier CG; Foss-Freitas MC; Paschoal RS; Tomazini MV; Simão JC; Foss MC; Foss NT
    J Am Acad Dermatol; 2009 May; 60(5):883-5. PubMed ID: 19389539
    [No Abstract]   [Full Text] [Related]  

  • 18. Intermittent dosing of biologics for psoriasis.
    Feldman SR
    J Dermatolog Treat; 2006; 17(1):5. PubMed ID: 16467016
    [No Abstract]   [Full Text] [Related]  

  • 19. Generalized pustular psoriasis and cryptogenic organizing pneumonia.
    Webber NK; Elston CM; O'Toole EA
    Br J Dermatol; 2008 Apr; 158(4):853-4. PubMed ID: 18241268
    [No Abstract]   [Full Text] [Related]  

  • 20. Tinea versicolor associated with etanercept therapy.
    Levy MS; Polsky D; Davidson A; Strober BE
    J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S99-100. PubMed ID: 18489062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.